Viewing Study NCT01047358


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-24 @ 6:37 AM
Study NCT ID: NCT01047358
Status: COMPLETED
Last Update Posted: 2015-10-08
First Post: 2009-12-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords: